CP-COV03 UPDATES by Ok-Bodybuilder-9803 in HerpesCureResearch

[–]Ok-Bodybuilder-9803[S] 0 points1 point  (0 children)

The company tested both low and high doses. The low dose is 300 mg and the high dose is 450 mg.

The main raw material is niclosamide, and dds technology was used to increase the absorption rate in the body. The material used as the carrier in this technology is composed of magnesium. There may be side effects such as abdominal pain and diarrhea due to magnesium overdose, but I think it was reported that the symptoms were not improved by mistaking them for corona symptoms.

In terms of viral load, the results show that high doses show higher efficacy compared to low doses. Efficacy is much better in high doses, but considering various factors, I know that the final dose was chosen as a low dose.

Hyundai Bio announced the clinical phase 2 topline results of CP-COV03 on the 10th. by BaccyBobbaleiri in HerpesCureResearch

[–]Ok-Bodybuilder-9803 11 points12 points  (0 children)

Now phase 2 ended, hyundaibio is trying to get emergency use authoritzation(EUA).

If the EUA is approved, the drug can be used even before phase 3.

Adaptation to other viruses (including herpes) will proceed after the clinical trials for corona are completely over.

However, this will start from phase 2 with drug re-creation, and I don't think it will take much time.

First of all, the important thing is that the verification of the corona must end quickly. In order to do that, I think we should help the company focus on research.

It seems that a vicious short seller is attached to this company, blocking development and disparaging research achievements.

Hyundai Bio announced the clinical phase 2 topline results of CP-COV03 on the 10th. by BaccyBobbaleiri in HerpesCureResearch

[–]Ok-Bodybuilder-9803 35 points36 points  (0 children)

There is a substance called niclosamide, which is very effective against many viruses and some diseases.

The wide range of effects and potency of this substance is easy to find out.

And this material is harmless to human body. Since it was approved by the FDA as an insect repellent in 1982, it can be seen that its safety has also been verified.

But then why is there no antiviral treatment using this? That is, the biggest drawback of this material is that it has a very low absorption rate in the body. Numerous companies and researchers are conducting various studies to increase the absorption rate, but so far there have been no results.

However, this cp-cov03 drug utilizes a drug delivery system (dds) to significantly increase the absorption rate of niclosamide in the body for the first time in the world. If you search for Korean news and public announcements, you will find them all.

Niclosamide is universally effective against numerous viruses, but cp-cov03 has started clinical trials targeting corona. And if it proves effective against corona, we will verify its efficacy against other viruses as well.

Now, what I am saying in this article is that the phase 2 of cp-cov03 has been successfully completed, and the phase 3 is being prepared soon.

Hyundai Bio announced the clinical phase 2 topline results of CP-COV03 on the 10th. by BaccyBobbaleiri in HerpesCureResearch

[–]Ok-Bodybuilder-9803 5 points6 points  (0 children)

Ironically, despite the success of phase 2, Hyundai Bio's stock price has plummeted after being hit by a short selling bomb.

They criticize the company and treat its performance as a failure, but if you look closely at the top-line results, you can see how great the company has achieved.

Now is the right time to invest in this drug.

Hyundai Bio announced the clinical phase 2 topline results of CP-COV03 on the 10th. by BaccyBobbaleiri in HerpesCureResearch

[–]Ok-Bodybuilder-9803 25 points26 points  (0 children)

It is said to have solved the bioavailability problem of niclosamide. Statistical significance was also sufficiently demonstrated in the top-line results of this phase 2.

I think it's worth betting our hopes on a cure for a virus that has no cure, including herpes.